Viruses 2012, 4(12), 3281-3302; doi:10.3390/v4123281
Review

Host Genetic Variants in the Pathogenesis of Hepatitis C

1email, 2email and 1,2,* email
Received: 26 October 2012; in revised form: 17 November 2012 / Accepted: 17 November 2012 / Published: 22 November 2012
(This article belongs to the Special Issue Hepatitis C Pathology)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Direct-acting antiviral drugs (DAAs) are currently replacing antiviral therapy for Hepatitis C infection. Treatment related side effects are even worse and the emergence of resistant viruses must be avoided because of the direct-antiviral action. Altogether it remains a challenge to take treatment decisions in a clinical setting with cost restrictions. Genetic host factors are hereby essential to implement an individualized treatment concept. In recent years results on different genetic variants have been published with a strong association with therapy response, fibrosis and treatment-related side effects. Polymorphisms of the IL28B gene were identified as accurate predictors for therapy response and spontaneous clearance of HCV infection and are already used for diagnostic decisions. For RBV-induced side effects, such as hemolytic anemia, associations to genetic variants of inosine triphosphatase (ITPA) were described and different SLC28 transporters for RBV-uptake have been successfully analyzed. Fibrosis progression has been associated with variants of Vitamin D receptor (VDR) and ABCB11 (bile salt export pump). Cirrhotic patients especially have a high treatment risk and low therapy response, so that personalized antiviral treatment is mandatory. This review focuses on different host genetic variants in the pathogenesis of Hepatitis C at the beginning of a new area of treatment.
Keywords: host genetics; Hepatitis C infection; IL28B; SVR; fibrosis progression
PDF Full-text Download PDF Full-Text [351 KB, uploaded 22 November 2012 14:13 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Rau, M.; Baur, K.; Geier, A. Host Genetic Variants in the Pathogenesis of Hepatitis C. Viruses 2012, 4, 3281-3302.

AMA Style

Rau M, Baur K, Geier A. Host Genetic Variants in the Pathogenesis of Hepatitis C. Viruses. 2012; 4(12):3281-3302.

Chicago/Turabian Style

Rau, Monika; Baur, Katharina; Geier, Andreas. 2012. "Host Genetic Variants in the Pathogenesis of Hepatitis C." Viruses 4, no. 12: 3281-3302.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert